Glossary

GLP-1 Weight Loss Program

A telehealth-delivered clinical weight loss program built around GLP-1 receptor agonist medications such as compounded semaglutide or tirzepatide.

A GLP-1 weight loss program combines clinical intake, provider prescribing, compounded medication fulfillment, and ongoing patient management into a structured offering. GLP-1 receptor agonists work by slowing gastric emptying and reducing appetite, which drives meaningful weight loss in most patients. The telehealth model makes these programs accessible without in-person visits, dramatically lowering the barrier for patients and the overhead for operators.

For operators, GLP-1 programs are the highest-demand product category in cash-pay telehealth today. Patient awareness of semaglutide and tirzepatide is high, acquisition costs are manageable with the right marketing, and monthly recurring revenue per patient is meaningful. The main operational challenges are clinical compliance, pharmacy supply chain, and patient retention beyond the first 90 days.

Karpa's GLP-1 program infrastructure includes branded intake funnels, AI-assisted triage, multi-state provider routing, pharmacy integrations for compounded semaglutide and tirzepatide, and automated follow-up workflows. Operators can launch a GLP-1 program in weeks without building any of this from scratch.

Related Solution

Launch your GLP-1 Weight Loss Program program with Karpa

See How It Works

Related Terms

Compounded Semaglutide Compounded Tirzepatide Cash-Pay Revenue Model

Frequently Asked Questions

How do operators differentiate their GLP-1 program in a crowded market? expand_more
Differentiation comes from brand, price point, patient experience, and support quality. Operators who invest in onboarding, check-in communications, and side effect management see better retention. Some add nutrition coaching or behavioral support to increase perceived value.
What clinical oversight is required for a GLP-1 program? expand_more
Patients require an initial provider evaluation, a valid prescription, and periodic follow-up. Most programs include monthly check-ins for the first 90 days and quarterly thereafter. Karpa automates follow-up scheduling and flags patients who have not completed required check-ins.
What is the typical patient retention rate for GLP-1 programs? expand_more
Retention varies significantly. Operators with strong onboarding and follow-up communications typically see 60 to 70 percent 3-month retention. Programs that provide minimal support after the initial prescription see higher dropout. Automated patient engagement, which Karpa supports, is one of the highest-leverage retention investments.

Ready to launch your clinic?

Karpa provides everything you need to go live in 2 weeks or less.

Book a Free Demo